MedTrace Logo

An European Union (EU) Post-Approval Registry of the TREO® Stent-Graft

NCT03187522 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 174

Last updated 2021-03-03

No results posted yet for this study

Summary

This is an EU sponsored trial and independent of the US trial registered under Clinicaltrials.gov ID NCT02009644.

The purpose of this registry is to gather clinical data on the safety and performance of the TREO Stent-Graft in patients with infrarenal abdominal aortic aneurysms. The registry is part of TREO's EU post-market surveillance plan providing long-term systematic clinical follow-up.

Conditions

  • Aortic Aneurysm, Abdominal

Interventions

DEVICE

TREO Stent-Graft System

The TREO® Stent-Graft is designed for use in the management of patients with AAAs and is composed of self-expanding nitinol stents sutured to polyester vascular graft fabric.

Sponsors & Collaborators

  • Bolton Medical Espana SLU

    collaborator UNKNOWN

  • Bolton Medical

    lead INDUSTRY

Principal Investigators

  • Giovanni Torsello, MD, PhD · Center of Vascular and Endovascular Surgery, Munster University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-22
Primary Completion
2020-12-30
Completion
2020-12-30

Countries

  • Belgium
  • Germany
  • Italy
  • Netherlands
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03187522 on ClinicalTrials.gov